Prevalence of different antibodies in the studied patients
| Positive Antibodies | SLE + APS, N (%) | SLE, N (%) | p |
|---|---|---|---|
| Anti-b2GP (IgG) | 11 (55.0) | 7 (35.0) | 0.203 |
| Anti-b2GP (IgM) | 12 (60.0) | 9 (45.0) | 0.34 |
| Acl (IgG) | 7 (35.0) | 5 (25.0) | 0.490 |
| Acl (IgM) | 5 (25.0) | 10 (50.0) | 0.102 |
| LAC | 9 (45.0) | 8 (40.0) | 0.749 |
| Anti-AII | 16 (80.0) | 8 (40.0) | 0.0098* |